久久精品30_一本色道久久精品_激情综合视频_欧美日韩一区二区高清_好看的av在线不卡观看_国产自产精品_91久久黄色_午夜亚洲福利_欧美黄在线观看_国内自拍一区

State Council's interagency task force briefing on promoting COVID-19 vaccination

The State Council's interagency task force held a press conference on Monday in Beijing to brief the media about issues on promoting COVID-19 vaccination.

China.org.cn March 19, 2021

CRNTT:

What is the suggested time between getting the COVID-19 vaccine and other vaccines? Is it possible to encounter an adverse reaction if you receive other vaccines after getting this one? Since China has carried out a massive domestic vaccination program, when are we expected to reach herd immunity? Thank you.

Li Bin:

This is a very specialized question, so I would like to invite Prof. Wang Huaqing to answer it.

Wang Huaqing:

Thanks for your question. Because the COVID-19 vaccine is new, the question you asked is not only a question that concerns the public but also one that professionals must conduct research on. Some time ago, we organized some experts to study and verify this issue. In order to monitor adverse reactions, suspected adverse reactions, and other considerations, we have studied whether tour novel coronavirus vaccine can be used simultaneously with other vaccines, and if not, how much time should there be between receiving vaccinations. Our findings show that at least two weeks' gap should be guaranteed between the COVID-19 vaccine and other vaccines. But in some special instances, the two weeks' recommendation can be waivered. For example, if someone has to be vaccinated against rabies or tetanus after being bitten by animals or are suffering trauma.

We all know that vaccines are external antigens that enter the human body. There will likely be some adverse reactions after vaccination, most of which will be normal reactions that will get better without treatment. However, sometimes there may be suspected adverse reactions with more severe symptoms. If that is the case, we recommend that the person goes to the hospital to receive timely diagnosis and treatment. During this process, if the doctor suspects that the adverse reactions were caused by the vaccine, the case will be reported and further investigation and diagnosis will be followed. In the future, we will continue to monitor and evaluate adverse reactions and suspected adverse reactions related to both the COVID-19 vaccine and other vaccines.

Just now you mentioned the issue of the immunological barrier, which is something that is of particular concern to the public, and also the direction in which we have been working hard. Everyone knows that COVID-19 is a disease that most or all the public is susceptible to. It has a very high severe co-morbidity rate for people with chronic diseases and the elderly, while some people may eventually lose their lives due to severe illness. According to the results of global monitoring, the global case fatality rate exceeds 2%, which is also relatively high. Under the circumstances, the key for us in controlling this disease is to rely on vaccines. As for other non-vaccine measures, China has made great efforts in various aspects in the early stages. The cost of taking non-vaccine prevention and control measures together has also been very high. We hope that in the future we will build an immunological barrier through vaccination. This is also the conclusion of our experience in controlling past infectious diseases.

Regarding the establishment of herd immunity, this has a lot to do with the protective efficacy of the vaccines and the population's vaccination rate. In the past, we eliminated smallpox and formed a population immunity of around 85% — that is the population immunity, not the vaccination rate. This means that the rate of people with immunity accounted for 85% of the whole population. Measles, which is more contagious, requires 95% of the population to be immune to block the disease. We have eliminated smallpox, and put forward the goal of eliminating measles. The goal of elimination is to prevent it from spreading, so the population must have high immunity.

COVID-19 vaccinations should be carried out step by step. The first step is to consider key populations, those with key jobs and who are at high risk of infection. The second step involves people who may be at risk of severe illness, and the third step involves other groups. In the end, all eligible members of the public will be vaccinated. This is the basis for the establishment of an immunological barrier or herd immunity. Of course, the establishment of such an immunological barrier requires efforts from all sides, including the public. Therefore, we hope that members of the public who received COVID-19 vaccination appointments will actively cooperate, and get vaccinated. Let's work together to build an immunological barrier, so that our studies, work and lives can return to normal. Thank you.

<  1  2  3  4  5  6  7  8  9  10  11  12  13  >  


Print E-mail Bookmark and Share
久久精品30_一本色道久久精品_激情综合视频_欧美日韩一区二区高清_好看的av在线不卡观看_国产自产精品_91久久黄色_午夜亚洲福利_欧美黄在线观看_国内自拍一区
久久国产麻豆精品| 一区在线观看| 日韩电影在线观看电影| 亚洲欧美韩国综合色| 国产欧美综合在线观看第十页| 久久伊人蜜桃av一区二区| 欧美一卡二卡在线观看| 欧美高清精品3d| 欧美一区二区在线看| 日韩精品在线一区| 精品88久久久久88久久久| 久久久综合精品| 国产精品电影一区二区| 18欧美亚洲精品| 亚洲一区二区美女| 日韩国产欧美在线观看| 精品无人码麻豆乱码1区2区| 国产一区高清在线| 不卡视频一二三四| 欧美日本免费| 亚洲色图自拍| 91久久精品午夜一区二区| 欧美日韩精品三区| 欧美va亚洲va| 国产精品麻豆久久久| 最近中文字幕一区二区三区| 天天操天天综合网| 国产真实乱对白精彩久久| 成人av综合在线| 精品成人在线| 在线观看不卡视频| 久久综合九色综合欧美就去吻| 欧美激情一区二区三区不卡 | 亚洲精品一区二区三区香蕉| 国产精品久久久久久久久动漫 | 久久精品亚洲国产奇米99| 中文字幕在线不卡| 奇米精品一区二区三区在线观看一| 国产美女一区二区| 欧美777四色影| 香蕉成人久久| 精品国产三级电影在线观看| 夜夜嗨av一区二区三区四季av| 美女www一区二区| 欧美+日本+国产+在线a∨观看| 国产视频一区在线观看一区免费| 欧美精品在线视频| 中文字幕在线观看一区| 激情综合色播激情啊| 亚洲特色特黄| 欧美日韩电影在线| 亚洲欧洲日本在线| 国产精品一区二区在线播放| 亚洲精品123区| 日韩亚洲欧美成人一区| 玉米视频成人免费看| 成人精品免费网站| 色综合久久天天| 国产丝袜在线精品| 激情综合网最新| 亚洲日本视频| 久久久精品tv| 另类欧美日韩国产在线| 亚洲国产精品www| 精品国产一区二区三区久久影院| 午夜a成v人精品| 激情自拍一区| 国产亚洲欧美一区在线观看| 久久精工是国产品牌吗| 亚洲视频二区| 欧美激情综合网| 国产成都精品91一区二区三| 久久看片网站| 一区二区三区美女| 91小视频免费看| 亚洲手机视频| 韩日精品视频| 欧美一区二区日韩一区二区| 亚洲国产综合91精品麻豆| 欧美国产三区| 欧美sm美女调教| 美女在线观看视频一区二区| 亚洲影院免费| 最新久久zyz资源站| 欧美一区激情| 国产午夜一区二区三区| 成人性生交大片免费看视频在线| 在线视频欧美精品| 欧美在线播放一区| 日韩欧美亚洲另类制服综合在线| 久久精品国产免费看久久精品| 国产乱码精品一区二区三区不卡| 日韩欧美一区在线| 麻豆国产精品视频| 欧美一区=区| 综合色中文字幕| 成人av一区二区三区| 3d成人h动漫网站入口| 偷拍自拍另类欧美| 国产欧美午夜| 亚洲精品乱码久久久久久黑人| 91美女精品福利| 欧美精品高清视频| 蜜臀av性久久久久蜜臀av麻豆| 一区二区av| 中文字幕一区二区在线播放 | 国产成人精品午夜视频免费| 色悠悠久久综合| 亚洲国产成人av网| 国产日韩欧美二区| 亚洲色欲色欲www在线观看| 精品动漫一区| 国产精品美女久久久久aⅴ| 成人免费观看视频| 91麻豆精品国产91久久久| 男男gaygay亚洲| 久久精品国产第一区二区三区最新章节| 一区二区三区四区不卡视频| 亚洲欧洲日本国产| 日韩极品在线观看| 色吧成人激情小说| 日韩**一区毛片| 在线免费观看成人短视频| 欧美aaa在线| 欧美专区在线观看一区| 久久精品国产99久久6| 欧亚洲嫩模精品一区三区| 亚洲午夜在线电影| 日本乱人伦一区| 国产精品资源在线看| 91精品欧美综合在线观看最新| 韩国女主播成人在线观看| 欧美四级电影网| av成人老司机| 亚洲与欧洲av电影| 美日韩精品视频| 日本不卡视频在线| 欧美一区二区三区啪啪| 91在线视频免费91| 国产精品美日韩| 宅男噜噜噜66国产日韩在线观看| 亚洲综合久久久| 色成年激情久久综合| 韩国女主播一区二区三区| 国产成人福利片| 亚洲日本黄色| 日本欧美一区二区三区| 欧美优质美女网站| 国产99久久久国产精品| 国产网站一区二区| 国内激情久久| 午夜精品久久久久久久99樱桃| 日本久久精品电影| 亚洲视频碰碰| 国产精品911| 亚洲一区二区三区激情| 精品婷婷伊人一区三区三| 99久久久国产精品免费蜜臀| 亚洲 欧美综合在线网络| 欧美日韩视频专区在线播放| 欧美黄污视频| 婷婷成人激情在线网| 精品99999| 一本久久a久久免费精品不卡| www.亚洲在线| 日韩精品一二三区| 国产拍欧美日韩视频二区| 欧美精品丝袜中出| 亚洲综合不卡| 国产精品v欧美精品v日韩| 毛片av一区二区| 亚洲综合另类小说| 中文字幕乱码久久午夜不卡| 69久久夜色精品国产69蝌蚪网| 在线亚洲国产精品网站| 91在线小视频| 粉嫩一区二区三区性色av| 日韩激情视频网站| 亚洲另类一区二区| 国产亚洲一本大道中文在线| 日韩一区二区三区av| 在线亚洲精品福利网址导航| 亚洲一区日韩在线| 亚洲第一在线综合在线| 97aⅴ精品视频一二三区| 国产一区二区三区免费播放| 午夜视频一区在线观看| 亚洲人成网站影音先锋播放| 国产日韩欧美精品一区| 欧美成人一区二区三区| 欧美精品乱码久久久久久按摩| 色噜噜狠狠一区二区三区果冻| 国产精品最新自拍| 国产精品毛片一区二区三区| 一区二区三区我不卡| 在线成人欧美| 一区二区av| 国产精品亚洲综合| 亚洲一区二区三区免费观看| 国产视频一区三区|